Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tyrosine kinase | 0.0077 | 0.0576 | 0.0957 |
Schistosoma mansoni | peptidylglycine monooxygenase | 0.0259 | 0.2972 | 0.4938 |
Entamoeba histolytica | hypothetical protein | 0.005 | 0.0222 | 0.489 |
Schistosoma mansoni | tyrosine kinase | 0.0046 | 0.0171 | 0.0285 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0046 | 0.0171 | 0.0498 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0145 | 0.147 | 0.4946 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0078 | 0.0587 | 0.0564 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.005 | 0.0214 | 0.0721 |
Schistosoma mansoni | phosphatidylinositol 4-kinase | 0.0054 | 0.0279 | 0.0463 |
Trypanosoma cruzi | phosphatidylinositol 4-kinase alpha, putative | 0.0066 | 0.0428 | 1 |
Echinococcus multilocularis | 0.0054 | 0.0279 | 0.0255 | |
Giardia lamblia | Phosphatidylinositol 4-kinase | 0.0054 | 0.0279 | 1 |
Echinococcus granulosus | Phosphatidylinositol 4 kinase type 2 beta | 0.021 | 0.2331 | 0.7823 |
Echinococcus multilocularis | insulin receptor | 0.0046 | 0.0171 | 0.0147 |
Echinococcus granulosus | Phosphatidylinositol 4 kinase type 2 beta | 0.021 | 0.2331 | 0.7823 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0024 | 0.0041 |
Leishmania major | phosphatidylinositol 4-kinase, putative | 0.0054 | 0.0279 | 0.2767 |
Trichomonas vaginalis | phosphatidylinositol kinase, putative | 0.0066 | 0.0428 | 0.1166 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.021 | 0.2331 | 0.7841 |
Brugia malayi | hypothetical protein | 0.0035 | 0.0024 | 0.0082 |
Echinococcus multilocularis | 0.0045 | 0.0152 | 0.0128 | |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0046 | 0.0171 | 0.0576 |
Loa Loa (eye worm) | hypothetical protein | 0.021 | 0.2331 | 0.7841 |
Trichomonas vaginalis | DNA-3-methyladenine glycosylase, putative | 0.0184 | 0.1991 | 1 |
Echinococcus granulosus | insulin receptor | 0.0046 | 0.0171 | 0.0498 |
Mycobacterium tuberculosis | Probable DNA-3-methyladenine glycosylase I TagA (tag I) (3-methyladenine-DNA glycosylase I, constitutive) (DNA-3-methyladenine g | 0.0091 | 0.0766 | 0.5 |
Echinococcus granulosus | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.005 | 0.0222 | 0.067 |
Schistosoma mansoni | tyrosine kinase | 0.0046 | 0.0171 | 0.0285 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.005 | 0.0222 | 0.0369 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.0074 | 0.0531 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.005 | 0.0222 | 0.489 |
Loa Loa (eye worm) | hypothetical protein | 0.0259 | 0.2972 | 1 |
Trichomonas vaginalis | DNA-3-methyladenine glycosylase, putative | 0.0184 | 0.1991 | 1 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.005 | 0.0222 | 0.489 |
Echinococcus granulosus | phosphatidylinositol 4 kinase beta | 0.0054 | 0.0279 | 0.0863 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.021 | 0.2331 | 0.7841 |
Echinococcus multilocularis | phosphatidylinositol 4 kinase alpha | 0.0066 | 0.0428 | 0.0405 |
Trichomonas vaginalis | phosphatidylinositol 4-kinase, putative | 0.0066 | 0.0428 | 0.1166 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.005 | 0.0222 | 0.489 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.005 | 0.0214 | 0.0721 |
Schistosoma mansoni | dopamine-beta-monooxygenase | 0.049 | 0.602 | 1 |
Echinococcus multilocularis | phosphatidylinositol 4,5 bisphosphate 3 kinase | 0.005 | 0.0222 | 0.0198 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.005 | 0.0222 | 0.0747 |
Schistosoma mansoni | phosphatidylinositol 4-kinase type-II | 0.021 | 0.2331 | 0.3872 |
Brugia malayi | phosphatidylinositol 4-kinase, catalytic, alpha polypeptide | 0.0066 | 0.0428 | 0.1441 |
Onchocerca volvulus | 0.021 | 0.2331 | 1 | |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0078 | 0.0587 | 0.1908 |
Leishmania major | phosphatidylinositol 4-kinase alpha, putative | 0.0066 | 0.0428 | 1 |
Echinococcus granulosus | phosphatidylinositol 4 kinase alpha | 0.0066 | 0.0428 | 0.137 |
Mycobacterium ulcerans | DNA-3-methyladenine glycosylase I TagA | 0.0184 | 0.1991 | 0.5 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.005 | 0.0214 | 0.0721 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0259 | 0.2972 | 1 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0259 | 0.2972 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.005 | 0.0222 | 0.0747 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0046 | 0.0171 | 0.0147 |
Brugia malayi | DOMON domain containing protein | 0.005 | 0.0214 | 0.0721 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0078 | 0.0587 | 0.1908 |
Echinococcus multilocularis | peptidyl glycine alpha amidating monooxygenase | 0.0259 | 0.2972 | 0.2955 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0203 | 0.0683 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.005 | 0.0222 | 0.0747 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0203 | 0.0683 |
Schistosoma mansoni | tyrosine kinase | 0.0077 | 0.0576 | 0.0957 |
Schistosoma mansoni | tyrosine kinase | 0.0078 | 0.0587 | 0.0975 |
Brugia malayi | Protein kinase domain containing protein | 0.0046 | 0.0171 | 0.0576 |
Trypanosoma cruzi | phosphatidylinositol 4-kinase, putative | 0.0054 | 0.0279 | 0.2767 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.021 | 0.2331 | 0.7841 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.005 | 0.0222 | 0.489 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0145 | 0.147 | 0.4946 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0203 | 0.0683 |
Schistosoma mansoni | phosphatidylinositol 4-kinase | 0.0066 | 0.0428 | 0.0711 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0145 | 0.147 | 0.1449 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.005 | 0.0222 | 0.0369 |
Trypanosoma cruzi | phosphatidylinositol 4-kinase alpha, putative | 0.0066 | 0.0428 | 1 |
Echinococcus granulosus | phosphatidylinositol 45 bisphosphate 3 kinase | 0.005 | 0.0222 | 0.067 |
Loa Loa (eye worm) | phosphatidylinositol 4-kinase type 3 alpha isoform 1 | 0.0066 | 0.0428 | 0.1441 |
Entamoeba histolytica | phosphatidylinositol-4,5-bisphosphate 3-kinase, putative | 0.005 | 0.0222 | 0.489 |
Schistosoma mansoni | phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K | 0.005 | 0.0222 | 0.0369 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0035 | 0.0024 | 0.0041 |
Loa Loa (eye worm) | hypothetical protein | 0.0259 | 0.2972 | 1 |
Onchocerca volvulus | 0.021 | 0.2331 | 1 | |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.021 | 0.2331 | 0.7841 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein | 0.0128 | 0.1241 | 0.4176 |
Echinococcus multilocularis | phosphatidylinositol 4 phosphate 3 kinase C2 | 0.005 | 0.0222 | 0.0198 |
Entamoeba histolytica | phosphatidylinositol 4-kinase, putative | 0.0066 | 0.0428 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0054 | 0.0279 | 0.0939 |
Trypanosoma cruzi | phosphatidylinositol 4-kinase, putative | 0.0054 | 0.0279 | 0.2767 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0203 | 0.0683 |
Plasmodium vivax | phosphatidylinositol 4-kinase, putative | 0.0054 | 0.0279 | 1 |
Brugia malayi | DOMON domain containing protein | 0.005 | 0.0214 | 0.0721 |
Schistosoma mansoni | tyrosine kinase | 0.0145 | 0.147 | 0.2442 |
Schistosoma mansoni | tyrosine kinase | 0.0077 | 0.0576 | 0.0957 |
Brugia malayi | DOMON domain containing protein | 0.005 | 0.0214 | 0.0721 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0145 | 0.147 | 0.4904 |
Schistosoma mansoni | tyrosine kinase | 0.0078 | 0.0587 | 0.0975 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0222 | 0.0747 |
Trypanosoma brucei | phosphatidylinositol 4-kinase alpha, putative | 0.0066 | 0.0428 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0054 | 0.0279 | 0.2767 |
Plasmodium falciparum | phosphatidylinositol 4-kinase | 0.0054 | 0.0279 | 1 |
Loa Loa (eye worm) | phosphatidylinositol kinase | 0.021 | 0.2331 | 0.7841 |
Toxoplasma gondii | phosphatidylinositol 3- and 4-kinase | 0.005 | 0.0222 | 0.1296 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0054 | 0.0279 | 0.0939 |
Echinococcus multilocularis | Phosphatidylinositol 4 kinase type 2 beta | 0.021 | 0.2331 | 0.2312 |
Schistosoma mansoni | peptidyl-glycine monooxygenase | 0.0259 | 0.2972 | 0.4938 |
Mycobacterium leprae | PROBABLE DNA-3-METHYLADENINE GLYCOSYLASE I TAGA (TAG I) (3-methyladenine-DNA glycosylase I, constitutive) (DNA-3-methyladenine g | 0.0091 | 0.0766 | 0.5 |
Brugia malayi | Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein | 0.0131 | 0.1292 | 0.4348 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.005 | 0.0222 | 0.0747 |
Echinococcus granulosus | phosphatidylinositol 3 kinase catalytic subunit | 0.005 | 0.0222 | 0.067 |
Entamoeba histolytica | phosphatidylinositol 3-kinase, putative | 0.005 | 0.0222 | 0.489 |
Echinococcus granulosus | peptidyl glycine alpha amidating monooxygenase | 0.0259 | 0.2972 | 1 |
Echinococcus multilocularis | Phosphatidylinositol 4 kinase type 2 beta | 0.021 | 0.2331 | 0.2312 |
Echinococcus multilocularis | Zinc finger, PHD finger | 0.005 | 0.0222 | 0.0198 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 22 % | Immunomodulatory activity in C57BL/6 mouse assessed as lymphopenia at 10 mg/kg, po after 6 hrs by complete blood count analysis | ChEMBL. | 19282175 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.